IMVT
Immunovant, Inc. · Healthcare
Director Atul Pande sold $192K of Immunovant, Inc.
Sold$192,000
$32.00Price
6,000Shares
−4%Stake
What IMVT did after the filing
- The stock from Thu, May 21 open, $35.62
- +12.5%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Jul 7 close.
Traded Wed, May 20. Filed Wed, May 20, 9:22 PM ET, after the close. Returns use the May 21 open and the Jul 7 close. Not investment advice.